{"id":22225,"date":"2026-06-17T12:00:00","date_gmt":"2026-06-17T10:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=a82d8e26ce5e4eb37671c5e9ec8452f0"},"modified":"2026-06-17T12:00:00","modified_gmt":"2026-06-17T10:00:00","slug":"zoya-technologies-launches-clinical-ai-terminal-engineered-to-operate-without-internet-connectivity","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=22225","title":{"rendered":"Zoya Technologies Launches Clinical AI Terminal Engineered to Operate Without Internet Connectivity"},"content":{"rendered":"

\nZoyeMed 3.0 Resilience Edition runs the complete Longitudinal Multimodal Model on-device, supporting a full medical episode - triage, examination, 120+ point-of-care tests, and prescription support - in fully disconnected environments<\/i><\/p><\/a><\/a><\/a><\/a>

DUBAI, United Arab Emirates--(BUSINESS WIRE)--Almost every digital health system assumes the internet will be there. Zoya Technologies<\/b> today launched the ZoyeMed 3.0 Resilience Edition<\/b>, a clinical AI terminal engineered to deliver a complete medical episode without an internet connection at any stage.<\/p>

\nContinuity of care is the first casualty of infrastructure disruption. Disasters, grid instability, and remote deployments routinely sever the connectivity that cloud-dependent systems require - when clinical capacity is most needed.<\/p>

\nThe Resilience Edition is a fully standalone configuration of ZoyeMed 3.0. The complete Longitudinal Multimodal Model and Zoyel.health clinical suite are resident on the device, executing locally on the company\u2019s proprietary Amygdala<\/i> edge AI engine. A terminal can operate indefinitely without a network connection.<\/p>

\n\u201cClinical intelligence should remain available to the patient and the clinician regardless of the state of the network around them,\u201d said Dr. Syed Sabahat Azim<\/b>, Chief Executive Officer of Zoya Technologies. \u201cWe have removed the cloud from the critical path of care - not as a feature, but as the architecture.\u201d<\/p>

\nIn a 5-square-metre footprint, the Resilience Edition delivers a complete medical episode in under 30 minutes. It integrates 12-lead ECG, digital stethoscopy, spirometry, dermatoscope, otoscope, fetal Doppler, a 12-camera telepresence array, and biochemistry, haematology, and immunoassay analysers supporting 120+ point-of-care tests. It operates in three modes: doctor-run, nurse-managed with remote clinician sign-off, and autonomous screening.<\/p>

\nThe Resilience Edition builds on existing ZoyeMed deployments across multiple regions, in commercial service since 2025. It is a human-in-the-loop system; final clinical decisions remain under the authority of a licensed clinician.<\/p>

\nZoya Technologies has also deployed an immutable audit trail across the platform - hash-chained, append-only records of every clinical action, particularly relevant in disconnected environments.<\/p>

\nThe Resilience Edition is available through Zoya Technologies\u2019 authorised distribution partners. Product imagery and the clinical white paper are available on request.<\/p>

\nAbout Zoya Technologies LLC<\/b><\/p>

\nZoya Technologies LLC is a deep-technology infrastructure company focused on building edge-native systems for real-world service delivery at scale. The company develops physically grounded, autonomous systems that integrate sensing, safety, and longitudinal intelligence, with healthcare as its first deployed domain.<\/p>

\nSource: <\/b>AETOSWire<\/b><\/a><\/p> Contacts<\/b>

\nSanket Santra\ncommunications@zoyel.one<\/a>+97142266599\nwww.zoyel.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

ZoyeMed 3.0 Resilience Edition runs the complete Longitudinal Multimodal Model on-device, supporting a full medical episode – triage, examination, 120+ point-of-care tests, and prescription support – in fully disconnected environmentsDUBAI, United Ara…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-22225","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/22225","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22225"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/22225\/revisions"}],"predecessor-version":[{"id":22226,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/22225\/revisions\/22226"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22225"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22225"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22225"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}